NCT05675605 2024-01-30
A Study of TY-1091 in Patients With Advanced Solid Tumors
TYK Medicines, Inc
Phase 1/2 Unknown
Clinical Trials
12 trialsNCT04031339 2023-05-10
ITCO
University of Roma La Sapienza
Unknown
NCT05278364 2023-04-12
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2 Unknown
NCT05796960 2023-04-04
ATCEU
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown
NCT04787328 2022-02-23
A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT04760171 2021-02-18
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis
The Leeds Teaching Hospitals NHS Trust
Unknown
NCT03643055 2020-11-04
18F-Fluorocholine PET/CT in Medullary Thyroid Cancer
University Medical Centre Ljubljana
Unknown
NCT03636945 2018-08-17
TEPCMT
Assistance Publique Hopitaux De Marseille
Phase NA Unknown
NCT01915485 2016-09-07
Radiolabeled Molecules for Medullary Thyroid Cancer
Instituto Nacional de Cancer, Brazil
Phase 4 Unknown
NCT01118065 2013-08-12
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01739634 2012-12-03
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Salient Pharmaceuticals Incorporated
Phase 1/2 Unknown
NCT01373736 2011-06-15
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Vancouver Coastal Health
Phase 3 Unknown